Improving coverage and completion rate of isoniazid preventive therapy among eligible HIV patients using quality improvement approaches: a case study of State Hospital, Ijebu Ode, Ogun State, Nigeria

被引:0
作者
Ogunsola, Olabanjo Okunlola [1 ]
Ajayi, Oluseye [1 ]
Ojo, Omobola [1 ]
Adeyeye, Oluwatomisin [1 ]
Akinro, Yewande [1 ]
Oke, Oluwabunmi [1 ]
Adurogbola, Adefolake Adebare [1 ]
Olajide, Olalere [1 ]
机构
[1] APIN Publ Hlth Initiat, Ibadan, Oyo State, Nigeria
关键词
HIV; isoniazid preventive therapy; quality improvement; TUBERCULOSIS;
D O I
10.11604/pamj.11/12/2019.34.193.19360
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: tuberculosis (TB) is a major killer of people living with HIV. One key strategy to reduce the incidence of tuberculosis in HIV patients is the use of Isoniazid Preventive Therapy (IPT). However, coverage of IPT among eligible HIV clients is poor. This study aims to improve IPT coverage using quality improvement approaches that help identify the root cause and improve coverage of isoniazid preventive therapy. Methods: the quality improvement (QI) project spanned over six months corresponding to three PDSA cycles. Root causes for low IPT initiation and completion in State Hospital Ijebu Ode were identified using fishbone analysis. The root causes were subjected to prioritization matrix and implementation plan was developed for the first two root causes with the highest composite matrix scores. Longitudinal data were collected over the six months period with learning session at the end of every two-month PDSA cycle. Data was analyzed using Microsoft Excel 2010 and presented in charts and tables. Results: the two most contributory factors to low IPT initiation and completion in the facility with prioritization matrix scores of 30 and 25 respectively were poor tracking system for IPT eligible clients and poor documentation of IPT commencement in the patients care cards and IPT registers. Findings showed improvement in both IPT initiation and completion with increase in initiation rate from 11% to above 50%, and increase in completion rate from 53% to 95.4%. Conclusion: the use of quality improvement approaches can improve coverage and completion rate of IPT among eligible HIV patients. Government and health programmers should support facilities to apply QI approaches to solving health service delivery.
引用
收藏
页数:9
相关论文
共 17 条
[1]  
[Anonymous], 2016, TREATMENT CARE NATL
[2]  
[Anonymous], 2011, Intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings
[3]   Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study [J].
Badri, M ;
Wilson, D ;
Wood, R .
LANCET, 2002, 359 (9323) :2059-2064
[4]   World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions [J].
Di Angelantonio, Emanuele ;
Kaptoge, Stephen ;
Pennells, Lisa ;
De Bacquer, Dirk ;
Cooney, Marie Therese ;
Kavousi, Maryam ;
Stevens, Gretchen ;
Riley, Leanne ;
Savin, Stefan ;
Altay, Servet ;
Amouyel, Philippe ;
Assmann, Gerd ;
Bell, Steven ;
Ben-Shlomo, Yoav ;
Berkman, Lisa ;
Beulens, Joline W. ;
Bjorkelund, Cecilia ;
Blaha, Michael J. ;
Blazer, Dan G. ;
Bolton, Thomas ;
Bonita, Ruth ;
Brenner, Beaglehole Hermann ;
Brunner, Eric J. ;
Casiglia, Edoardo ;
Chamnan, Parinya ;
Choi, Yeun-Hyang ;
Chowdhury, Rajiv ;
Coady, Sean ;
Crespo, Carlos J. ;
Cushman, Mary ;
Dagenais, Gilles R. ;
D'Agostino, Ralph B. ;
Daimon, Makoto ;
Davidson, Karina W. ;
Engstrom, Gunnar ;
Fang, Xianghua ;
Ford, Ian ;
Gallacher, John ;
Gansevoort, Ron T. ;
Gaziano, Thomas Andrew ;
Giampaoli, Simona ;
Grandits, Greg ;
Grimsgaard, Sameline ;
Grobbee, Diederick E. ;
Gudnason, Vilmundur ;
Guo, Qi ;
Humphries, Steve ;
Iso, Hiroyasu ;
Jukema, J. Wouter ;
Kauhanen, Jussi .
LANCET GLOBAL HEALTH, 2019, 7 (10) :E1332-E1345
[5]   The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) Study [J].
Durovni, Betina ;
Cavalcante, Solange C. ;
Saraceni, Valeria ;
Vellozo, Vitoria ;
Israel, Giselle ;
King, Bonnie S. ;
Cohn, Silvia ;
Efron, Anne ;
Pacheco, Antonio G. ;
Moulton, Lawrence H. ;
Chaisson, Richard E. ;
Golub, Jonathan E. .
AIDS, 2010, 24 :S49-S56
[6]  
Hawken MP, 1999, INT J TUBERC LUNG D, V3, P646
[7]  
Khabo Bekezela Bobbie, 2017, FACTORS ASS UPTAKE I
[8]   Perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study [J].
Mindachew, Mesele ;
Deribew, Amare ;
Memiah, Peter ;
Biadgilign, Sibhatu .
PAN AFRICAN MEDICAL JOURNAL, 2014, 17
[9]   Impact of Antiretroviral Therapy on the Incidence of Tuberculosis: The Brazilian Experience, 1995-2001 [J].
Miranda, Abraham ;
Morgan, Meade ;
Jamal, Leda ;
Laserson, Kayla ;
Barreira, Draurio ;
Silva, Guida ;
Santos, Joseney ;
Wells, Charles ;
Paine, Patricia ;
Garrett, Denise .
PLOS ONE, 2007, 2 (09)
[10]  
Moolphate Saiyud, 2013, Glob J Health Sci, V5, P60, DOI 10.5539/gjhs.v5n4p60